BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38068343)

  • 1. Expression of p53, p63, p16, Ki67, Cyclin D, Bcl-2, and CD31 Markers in Actinic Keratosis, In Situ Squamous Cell Carcinoma and Normal Sun-Exposed Skin of Elderly Patients.
    Balcere A; Sperga M; Čēma I; Lauskis G; Zolovs M; Rone Kupfere M; Krūmiņa A
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
    Hodges A; Smoller BR
    Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
    Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
    An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study.
    Neto PD; Alchorne M; Michalany N; Abreu M; Borra R
    Indian J Dermatol; 2013 Jul; 58(4):325. PubMed ID: 23919015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
    Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
    Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
    Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
    Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").
    Cockerell CJ
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 2):11-7. PubMed ID: 10607351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
    Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
    Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression.
    Bito T; Ueda M; Ahmed NU; Nagano T; Ichihashi M
    J Cutan Pathol; 1995 Oct; 22(5):427-34. PubMed ID: 8594075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.
    Einspahr JG; Alberts DS; Warneke JA; Bozzo P; Basye J; Grogan TM; Nelson MA; Bowden GT
    Neoplasia; 1999 Nov; 1(5):468-75. PubMed ID: 10933063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
    Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
    J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.
    Mortier L; Marchetti P; Delaporte E; Martin de Lassalle E; Thomas P; Piette F; Formstecher P; Polakowska R; Danzé PM
    Cancer Lett; 2002 Feb; 176(2):205-14. PubMed ID: 11804749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.